← Back to all articles

Articles · Earnings, Guidance Tracker

Baxter International (BAX) Q3 2026 Earnings: Guidance Raised

Q3 2026 (ended Sep 30, 2026): revenue, EPS and full-year guidance from the SEC filing

Published Nov 5, 2026

TL;DR

  • Baxter International raised its full-year guidance; revenue +5.0% vs a year earlier.

Baxter International's results for Q3 2026 (ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-29. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.

At a glance

ItemValue
Revenue (GAAP)$2,976 million (+5.0% vs a year earlier)
Diluted EPS (GAAP)$0.57
Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs)$0.58
Full-year guidanceRaised

Guidance

Raised 2026 outlook: reported sales growth 4%–5% (from 3%–4%), organic 3%–4% (from 2%–3%), adjusted EPS $2.05–2.15 (from $1.95–2.15).

Why this label: 'Raised its full-year financial outlook': sales growth 4-5% (prev 3-4%), adjusted EPS $2.05-$2.15 (prev $1.95-$2.15).

MetricPeriodNewPrior (as stated in the release)
reported sales growth (continuing operations)FY20264%–5%3%–4%
organic sales growth (continuing operations)FY20263%–4%2%–3%
adjusted EPS (continuing operations)FY2026$2.05–2.15$1.95–2.15

From the release

Revenue: "NET SALES · $ · 2,976 · $ · 2,835 · 5%"

Earnings per share: "Third-quarter U.S. GAAP 3 diluted earnings per share (EPS) of $0.57; adjusted diluted EPS of $0.58"

reported sales growth (continuing operations): "Reported sales growth from continuing operations: 4% to 5% (previously 3% to 4%)"

organic sales growth (continuing operations): "Organic sales growth from continuing operations: 3% to 4% (previously 2% to 3%)"

adjusted EPS (continuing operations): "Adjusted earnings from continuing operations per diluted share: $2.05 to $2.15 (previously $1.95 to $2.15)"

Quotes are copied from the filing; in table rows, cell borders are shown as “·”.

Key fact: Raised 2026 outlook; Q3 sales rose 5% to $2.98 billion with growth in all segments.

Source

Baxter International earnings release (SEC filing), accession 0000010456-26-000004, filed 2026-10-29.

Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.

Get the Sunday Recap by email

One email a week. Every issue is published on the site too, so this is only about getting it in your inbox.

Subscribing signs you up for the free YieldTerminal Sunday recap, one email a week. Educational only, not financial advice. Unsubscribe any time.

Educational commentary, not a recommendation to buy or sell anything.